Potential antiviral role of p53 in HCV-infected patients

被引：0
|
作者：
Hamdi, N. [1 ]
El-Serafy, M. [2 ]
Esmat, G. [2 ]
Alaakel, W. [2 ]
Abdelaziz, A. I. [1 ]
机构：
[1] German Univ Cairo, Cairo, Egypt
[2] Cairo Univ, Cairo, Egypt
来源：
FEBS JOURNAL | 2009年 / 276卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [1] Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients
    Leveri, M
    Gritti, C
    Rossi, L
    Zavaglia, C
    Civardi, E
    Mondelli, MU
    De Silvestri, A
    Silini, EM
    CANCER LETTERS, 2004, 208 (01) : 75 - 79
  • [2] Antiviral therapy in HCV-infected cirrhotic patients awaiting liver transplantation
    Carrion, Jose A.
    Navasa, Miquel
    Forns, Xavier
    JOURNAL OF HEPATOLOGY, 2009, 51 (05) : 960 - 962
  • [3] Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective
    El-Fishawy, Hussein
    Saadi, Gamal
    Hassaballa, May
    Hussein, Mohamed
    Doss, Wahid
    Ragab, Gaafar
    Barsoum, Rashad
    JOURNAL OF ADVANCED RESEARCH, 2016, 7 (03) : 391 - 402
  • [4] The German multicenter cohort on direct antiviral agents in HCV- and HIV/HCV-infected patients (GECODAA)
    Hueppe, D.
    Christensen, S.
    Ingiliz, P.
    Schewe, K.
    Simon, K. G.
    Boesecke, C.
    Lutz, T.
    Baumgarten, A.
    Busch, H.
    Schmutz, G.
    Mauss, S.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 14 - 15
  • [5] Safety of cyclosporin a in HCV-infected patients
    Galeazzi, Mauro
    Bellisai, Francesca
    Giannitti, Chiara
    Manganelli, Stefania
    Morozzi, Gabriella
    Sebastiani, Gian Domenico
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 544 - 549
  • [6] Overweight is associated with diminished antiviral response in HCV-infected children
    Delgado-Borrego, Aymin
    Christofe, Marielle
    Healey, David
    Ludwig, David A.
    Jonas, Maureen M.
    Chung, Raymond T.
    HEPATOLOGY, 2007, 46 (04) : 277A - 277A
  • [7] Dual Role of p53 in Innate Antiviral Immunity
    Rivas, Carmen
    Aaronson, Stuart A.
    Munoz-Fontela, Cesar
    VIRUSES-BASEL, 2010, 2 (01): : 298 - 313
  • [8] P53 mediated cellular pathways: Potential role in HCV associated liver injury
    Sarfraz, S.
    Hamid, S.
    Siddiqui, A. A.
    Jafri, A.
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S115 - S115
  • [9] HCV-infected dialysis patients: History is changing
    Parlati, Lucia
    Pol, Stanislas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 225 - 227
  • [10] DISPARATE ACCESS TO NEW ANTIVIRAL TREATMENT REGIMENS AFFECTS QUALITY OF LIFE IN HCV-INFECTED PATIENTS
    Rocco, A.
    Angrisani, D.
    Carbone, M.
    Sgamato, C.
    Zamparelli, M. Sanduzzi
    Coccoli, P.
    Compare, D.
    Nardone, G.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E194 - E194
12345